These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18267243)

  • 1. Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD.
    Mandel SA; Fishman T; Youdim MB
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S242-7. PubMed ID: 18267243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
    Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
    Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic aspects of sporadic Parkinson's disease.
    Riederer P; Youdim MB; Mandel S; Gerlach M; Grünblatt E
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S88-91. PubMed ID: 18585078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
    Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic contributions to Parkinson's disease.
    Huang Y; Cheung L; Rowe D; Halliday G
    Brain Res Brain Res Rev; 2004 Aug; 46(1):44-70. PubMed ID: 15297154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor PITX3 is associated with sporadic Parkinson's disease.
    Fuchs J; Mueller JC; Lichtner P; Schulte C; Munz M; Berg D; Wüllner U; Illig T; Sharma M; Gasser T
    Neurobiol Aging; 2009 May; 30(5):731-8. PubMed ID: 17905480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal pathology in Parkinson's disease.
    Schulz JB; Falkenburger BH
    Cell Tissue Res; 2004 Oct; 318(1):135-47. PubMed ID: 15365812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing/overexpressing selected genes as a model of sporadic Parkinson's disease.
    Fishman-Jacob T; Youdim MB; Mandel SA
    Neurodegener Dis; 2010; 7(1-3):108-11. PubMed ID: 20173338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease.
    McNaught KS; Olanow CW
    Neurobiol Aging; 2006 Apr; 27(4):530-45. PubMed ID: 16207501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis.
    Pienaar IS; Dexter DT; Burkhard PR
    Expert Rev Proteomics; 2010 Apr; 7(2):205-26. PubMed ID: 20377388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C; Lee SJ
    J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis of Parkinson's disease.
    Gandhi S; Wood NW
    Hum Mol Genet; 2005 Sep; 14(18):2749-55. PubMed ID: 16126732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the role of defective genes in Parkinson's disease.
    Dawson TM
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S248-9. PubMed ID: 18267244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-environment interactions in sporadic Parkinson's disease.
    Benmoyal-Segal L; Soreq H
    J Neurochem; 2006 Jun; 97(6):1740-55. PubMed ID: 16805780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.
    Ferrer I; Perez E; Dalfó E; Barrachina M
    Neurosci Lett; 2007 Mar; 415(3):205-9. PubMed ID: 17284347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic neurons reduced to silence by oxidative stress: an early step in the death cascade in Parkinson's disease?
    Michel PP; Ruberg M; Hirsch E
    Sci STKE; 2006 Apr; 2006(332):pe19. PubMed ID: 16639033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein and Parkinson's disease: a proteomic view.
    Fasano M; Lopiano L
    Expert Rev Proteomics; 2008 Apr; 5(2):239-48. PubMed ID: 18466054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra.
    Noureddine MA; Li YJ; van der Walt JM; Walters R; Jewett RM; Xu H; Wang T; Walter JW; Scott BL; Hulette C; Schmechel D; Stenger JE; Dietrich F; Vance JM; Hauser MA
    Mov Disord; 2005 Oct; 20(10):1299-309. PubMed ID: 15966006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-environment interactions in Parkinson's disease.
    Ross CA; Smith WW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S309-15. PubMed ID: 18267256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease.
    Hatano T; Kubo S; Sato S; Hattori N
    J Neurochem; 2009 Dec; 111(5):1075-93. PubMed ID: 19780902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.